GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » EV-to-EBITDA

Turmeric Acquisition (Turmeric Acquisition) EV-to-EBITDA : 0.00 (As of Jun. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Turmeric Acquisition's enterprise value is $0.00 Mil. Turmeric Acquisition's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $2.54 Mil. Therefore, Turmeric Acquisition's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Turmeric Acquisition's EV-to-EBITDA or its related term are showing as below:

TMPMU' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0   Max: 51.14
Current: 49.81

During the past 2 years, the highest EV-to-EBITDA of Turmeric Acquisition was 51.14. The lowest was 0.00. And the median was 0.00.

TMPMU's EV-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 9.54 vs TMPMU: 49.81

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-13), Turmeric Acquisition's stock price is $9.99. Turmeric Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.000. Therefore, Turmeric Acquisition's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Turmeric Acquisition EV-to-EBITDA Historical Data

The historical data trend for Turmeric Acquisition's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition EV-to-EBITDA Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
EV-to-EBITDA
- 46.57

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBITDA Get a 7-Day Free Trial - -122.80 46.57 50.58 49.31

Competitive Comparison of Turmeric Acquisition's EV-to-EBITDA

For the Shell Companies subindustry, Turmeric Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turmeric Acquisition's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Turmeric Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Turmeric Acquisition's EV-to-EBITDA falls into.



Turmeric Acquisition EV-to-EBITDA Calculation

Turmeric Acquisition's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/2.544
=0.00

Turmeric Acquisition's current Enterprise Value is $0.00 Mil.
Turmeric Acquisition's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turmeric Acquisition  (NAS:TMPMU) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Turmeric Acquisition's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.99/0.000
=N/A

Turmeric Acquisition's share price for today is $9.99.
Turmeric Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Turmeric Acquisition EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Turmeric Acquisition (Turmeric Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005